Who Paid My Doc
Lindsey Beverly
Physician Assistant Denver, CO Physician Assistant
NPI 1174083570 CMS profile 10862203
2045 N Franklin St, Ste 350, Denver, CO 80205
General payments
$3,083
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Lindsey Beverly of Denver, CO is reported in the CMS Open Payments database as having received $3,083 across 97 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 86th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $110 | 2 | |
| 2024 | General | $211 | 3 | |
| 2023 | General | $504 | 8 | |
| 2022 | General | $1,071 | 41 | |
| 2021 | General | $1,188 | 43 |
Beside peers
- Lindsey Beverly
- Physician Assistant median
- Middle half of Physician Assistant
- National median
In program year 2025, general payments to Lindsey Beverly were reported at $110. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.
Show as a table
| Year | Lindsey Beverly | Physician Assistant median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $34 | $17–$122 | $163 |
| 2020 | $0 | $33 | $16–$78 | $114 |
| 2021 | $1,188 | $132 | $37–$438 | $132 |
| 2022 | $1,071 | $155 | $48–$522 | $149 |
| 2023 | $504 | $167 | $52–$557 | $160 |
| 2024 | $211 | $178 | $55–$600 | $164 |
| 2025 | $110 | $184 | $57–$620 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 16 drugsPart D claims
1,480
Drug cost
$312,161
Branded share of claims
27.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | Brand | 199 | $241,348 | |
| Jardiance Empagliflozin | Brand | 141 | $54,256 | |
| Metoprolol Succinate | Generic | 214 | $3,047 | |
| Spironolactone | Generic | 253 | $2,550 | |
| Furosemide | Generic | 172 | $2,077 | |
| Losartan Potassium | Generic | 141 | $1,669 | |
| Potassium Chloride | Generic | 24 | $1,248 | |
| Carvedilol | Generic | 83 | $1,199 | |
| Bisoprolol Fumarate | Generic | 35 | $946 | |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | Brand | 49 | $917 |
The 10 drugs with the highest cost, of 16 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Records
97 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physician Assistant in Colorado
Donald Moore
Physician Assistant · Englewood, CO
Neekan Aeini
Physician Assistant · Greenwood Village, CO
Korby Howell
Physician Assistant · Cortez, CO
Heather Finlayson
Physician Assistant · Littleton, CO
Kristen Lervik
Physician Assistant · Denver, CO
Marissa Moritz-Guzik
Physician Assistant · Louisville, CO
Related records
Physician Assistant in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.